Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus midazolam during extubation in hypertensive orthopedic surgery patients
IRCT20190325043107N26Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in hypertension (HTN) comparing Dexmedetomidine arm with Midazolam control arm (2 arms). Primary endpoint: Hemodynamic status. Started Feb 2022; status: completed.
02
Drugs
dexmedetomidinemidazolam
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20190325043107N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N26.